Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL221P is a **pseudogene** annotated as "RNA, 7SL, cytoplasmic 221, pseudogene." It is part of the large family of dispersed **7SL RNA pseudogenes** in the human genome. These pseudogenes are DNA sequences similar to the functional 7SL RNA gene but lack the ability to form functional SRP RNA or contribute to protein targeting in the cell. Pseudogenes typically arise via duplication events or reverse transcription, and nearly all are considered nonfunctional—incapable of producing functional RNA or protein products. Pseudogenes such as RN7SL221P may be transcribed at low levels but usually have no verified role in cellular biology; in certain situations, pseudogene transcripts can complicate genetic studies, but no evidence exists for direct biological or therapeutic relevance for RN7SL221P[2][7][8][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 221, pseudogene (RN7SL221P).